In vivo anti-diabetic and anti-oxidant potential of psoralea corylifolia seeds in streptozotocin induced type-2 diabetic rats

Journal of Health Science

Volumn 57, Issue 3, 2011, Pages 225-235

  Kamboj, Jitpal ^a   Sharma, Sunil ^a   Kumar, Suresh ^a  

^a GURU JAMBHESHWAR UNIVERSITY OF SCIENCE AND TECHNOLOGY   (India)

Author keywords

Glibenclamide; Hyperglycaemia; Psoralea corylifolia; Streptozotocin

Indexed keywords

CHOLESTEROL; GLIBENCLAMIDE; GLUCOSE; GLUTATHIONE; GLYCOGEN; HEMOGLOBIN A1C; INSULIN; MALONALDEHYDE; PSORALEA CORYLIFOLIA EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DRUG DOSE COMPARISON; GLUCOSE BLOOD LEVEL; GLYCOGEN LIVER LEVEL; HYPERGLYCEMIA; IN VIVO STUDY; INSULIN BLOOD LEVEL; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PLANT SEED; RAT; STREPTOZOCIN DIABETES; WEIGHT GAIN;

CULLEN CORYLIFOLIA; RATTUS; RATTUS NORVEGICUS;

EID: 79958029190     PISSN: 13449702     EISSN: 13475207     Source Type: Journal    
DOI: 10.1248/jhs.57.225     Document Type: Article

References (48)

1. Zimmet, P., Alberti, K. G. and Shaw, J. (2001) Global and societal implications of the diabetes epidemic. Nature, 414, 782-787.
2. Harris, M. I., Hadden, W. C., Knowler, W. C. and Bennett, P. H. (1987) Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in U.S. population aged 20-74. Diabetes, 36, 523-534.
3. National Diabetes Data Group (1979) Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes, 28, 1039-1057.
4. Somani, R., Kasture, S. and Singhai, A. K. (2006) Antidiabetic potential of Butea monosperma in rats. Fitoterapia, 77, 86-90.
5. Kumar, P. J. and Clark, M. (2002) Diabetes mellitus and other disorders of metabolism. In Textbook of Clinical Medicines, Saunders, London, pp. 1069-1152.
6. Yadava, R. N. and Verma, Y. A. (2005) A new biologically active flavonol glycoside from Psoralea corylifolia (Linn.). J. Asian Nat. Prod. Res., 7, 671-675.
7. Miura, H., Nishida, H. and Linuma, M. (1996) Effect of crude fractions of Psoralea corylifolia seed extract on bone calcification. Planta Med., 62, 150-153.
8. Ahmed, I., Adeghate, E., Cummings, E., Sharma, A. K. and Singh, J. (2004) Beneficial effects and mechanism of action of Momordica charantia juice in the treatment of streptozotocin-induced diabetes mellitus in rat. Mol. Cell. Biochem., 26, 63-70.
9. Kotiyal, J. P. and Sharma, D. P. (1992) Phytochemical studies of Psoralea species. Bulletin of Medico-Ethnobotanical Research, 13, 209-223.
10. Tsai, W. J., Hsin, W. C. and Chen, C. C. (1996) Antiplatelet flavonoids from seeds of Psoralea corylifolia. J. Nat. Prod., 59, 671-672.
11. Bensky, D. and Gamble, A. (1993) Chinese Herbal Medicine: Materia Medica, Revised edition, Eastland Press, Washington, pp. 344-345.
12. Chino, M., Sato, K., Yamazaki, T. and Maitani, T. (2002) Constituent of natural food additive hokosshi extract and an analytical method for the additive in foods. Shokuhin Eiseigaku Zasshi, 43, 352-355.
13. National Commission of Chinese Pharmacopoeia (2005) Pharmacopoeia of the People's Republic of China, Vol. 1, Chemical Industry Press, Beijing, pp. 129-130.
14. Yin, S., Fan, C. Q., Wang, Y., Dong, L. and Yue, H. M. (2004) A Rapid Method for the Analysis of Ten Compounds in Psoralea corylifolia L. by UPLC. Bioorg. Med. Chem., 12, 4387-4392.
15. Khatune, N. A., Islam, M. E., Khondkar, P. and Rahman, M. M. (2004) Antibacterial compounds from the seeds of Psoralea corylifolia. Fitoterapia, 75, 228-230.
16. Zhu, D. Y., Chen, Z. X., Liu, J. S., Huang, B. S., Xie, Y. Y. and Zeng, G. F. (1979) Studies on chemical constituents of Bu-gu-zhi, the seeds of Psoralea corylifolia. Acta Pharmacol. Sin., 14, 605-611.
17. Yang, Y. M., Hyun, J.W., Sung, M. S., Chung, H. S., Kim, B. K., Paik, W. H., Kang, S. S. and Park, J. G. (1996) The cytotoxicity of psoralidin from Psoralea corylifolia. Planta Med., 62, 353-354.
18. Masiello, P., et al. (1998) Experimental NIDDM: development of a new model in adult rats administered streptozotocin and nicotinamide. Diabetes, 47, 224-229.
19. Okhawa, H., Ohishi, N. and Yagi, K. (1979) Assay for lipid peroxides in animal tissue by thiobarbituric acid reaction. Anal. Biochem., 95, 351-358.
20. Sedlak, J. and Lindsay, R. H. (1968) Estimation of total protein bound and non protein bound sulfhydryl group in tissue with ellman's reagent. Anal. Biochem., 15, 192-205.
21. Seifter, S., Dayton, S., Molic, B. and Mutwzter, E. (1950) The estimation of glycogen with the anthrone reagent. Archives of Biochemistry, 25, 191-200.
22. Bailey, C. J. and Day, C. (1989) Traditional plant medicines as treatments for diabetes. Diabetes Care, 12, 553-564.
23. Mohamed, A. K., Bierhaus, A., Schiekofer, S., Tritschler, H., Ziegler, H. and Nawroth, P. P. (1999) The role of oxidative stress and NF (B) activation in late diabetic complications. Biofactors, 10, 175-179.
24. Donnini, D., Zambito, A. M., Perrella Gambesi-Impiombato, F. S. and Cur-cio, F. (1996) Glucose may induce cell death through a free radical mediated mechanism. Biochem. Biophys. Res. Commun., 219, 412-417.
25. Baynes, J. W. and Thorpe, S. R. (1999) Role of oxidative stress in diabetic complications. Diabetes Care, 48, 1-9.
26. Ozturk, Y., Altan, V. M. and Yildizoglu, A. (1996) Effect of experimental diabetes and insulin on smooth muscle function. Pharmacol Rev., 48, 69-112.
27. Szkudelski, T. (2001) The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol. Res., 50, 537-546.
28. Pathak, D., Pathak, K. and Singla, A. K. (1991) Flavonoids as medicinal agents-recent advances. Fitoterapia, 62, 371-389.
29. Ahmad, M., Akhtar, M. S., Malik, T. and Gilani, A. H. (2000) Hypoglycemic action of flavonoids fraction of Cuminum nigrum seeds. Phytother. Res., 14, 103-106.
30. Chakravarti, B. K., Gupta, S., Gambir, S. S. and Gode, K. D. (1981) Pancreatic betacell regeneration in rats by (-) epicatechin. Lancet, 2, 759-760.
31. Swanston-Flat, S. K., Day, C., Bailey, C. J. and Flatt, P. R. (1990) Traditional plant treatments for diabetes studies in normal and streptozotocin diabetic mice. Diabetologia, 33, 462-464.
32. Vats, V. and Grover, J. K. (2004) Ethanolic extract of Ocimum sanctum leaves partially attenuates streptozotocin-induced alteration in glycogen content and carbohydrate metabolism in rats. J. Ethnopharmacol., 90, 11-24.
33. Pari, L. and Latha, M. (2002) Effect of cassia auriculata flower on blood sugar levels, serum and tissue lipids in streptozotocin diabetic rats. Singapore Med. J., 43, 617-621.
34. Chattopadhyay, R. R. (1999) Possible mechanism of antihyperglycemic effect of Azadirachta indica leaf extract. Part V. J. Ethnopharmacol., 67, 373-376.
35. Alyassin, D. and Ibrahim, K. (1981) A minor haemoglobin fraction and the level of fasting blood glucose. J. Fac. Med. Baghdad, 23, 373-380.
36. Sheela, G. C. and Augusti, K. (1992) Antidiabetic effects of S-allyl cystine sulphoxide isolated from garlic Allium sativum Linn. Indian J. Exp. Biol., 30, 523-526.
37. Bunn, H. G., Gabby, K. H. and Gallop, P. M. (1978) The glycosylation of hemoglobin: relevance to diabetes mellitus. Science, 200, 21-27.
38. Al-Shamaony, L., Al-Khazraji, S. M. and Twaji, H. A. (1994) Hyperglycaemic effect of Artemisia herb alba II. Effect of a valuable extract on some blood parameters in diabetic animals. J. Ethnopharmacol., 43, 167-171.
39. Akatsuka, A., Singh, T. J. and Huang, K. P. (1983) Comparison of liver glycogen synthase from normal and streptozotocin-induced diabetic rats. Arch. Biochem. Biophys., 220, 426-434.
40. Stalmans, W. and Cadefau, W. S. (1997) New insight into the regulation of liver glycogen metabolism by glucose. Biochem. Soc. Trans., 25, 19-25.
41. Haung, X., Vaag, A., Hanson, M., Weng, J. and Goop, L. (2000) Impaired insulin stimulated expression of the glycogen synthase gene in skeletal muscle of type 2 diabetic parents is acquired rather than inherited. J. Clin. Endocrinol. Metab., 85, 1584-1590.
42. Gupta, B. L., Nehal, M. and Banquer, N. Z. (1997) Effect of experimental diabetes on the activity of hexokinase, glucose-6-phosphate dehydrogenase and catecholamine in rats erythrocytes of different ages. Indian J. Exp. Biol., 35, 792-795.
43. Giuglino, D., Ceriello, A. and Paolisso G. (1996) Oxidative stress and diabetic vascular complication. Diabetes Care, 19, 257-267.
44. Vandum, P. S. and Van, B. S. (1995) The role of oxidative stress in neuropathy and other other diabetic complication. Diabetes Metab., 11, 181-192.
45. Exner, R. and Wessner, B. (2000) Therapeutic potential of glutathione. Wien. Klin. Wochenschr., 112, 610-615.
46. Anuradha, C. V. and Selvam, R. (1993) Effect of oral methionine on tissue lipid peroxidation and antioxidants in alloxan-induced diabetic rats. J. Nutr. Biochem., 4, 211-217.
47. Matcovis, B., Varga, S. I., Szaluo, L. and Witsas, H. (1994) The effect of diabetes on the activities of the peroxide metabolic enzymes. Horm. Metab. Res., 14, 77-79.
48. Lee, A. Y. and Chung, S. S. (1999) Contribution of polyl pathway to oxidative stress in diabetic cataract. FASEB J., 13, 23-30.